Variant report
Variant | esv11055 |
---|---|
Chromosome Location | chr2:231437916-231440779 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:66)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF3 | chr2:231440402-231440663 | K562 | blood: | n/a | n/a |
2 | CBX3 | chr2:231440344-231440726 | K562 | blood: | n/a | n/a |
3 | CTCF | chr2:231440140-231440290 | HepG2 | liver: | n/a | n/a |
4 | E2F6 | chr2:231440466-231440616 | K562 | blood: | n/a | n/a |
5 | EP300 | chr2:231440532-231440642 | K562 | blood: | n/a | n/a |
6 | FOSL1 | chr2:231440361-231440717 | K562 | blood: | n/a | chr2:231440575-231440584 |
7 | GABPA | chr2:231438461-231438645 | Hela-S3 | cervix: | n/a | n/a |
8 | GATA3 | chr2:231437834-231438207 | MCF-7 | breast: | n/a | n/a |
9 | HCFC1 | chr2:231440498-231440638 | K562 | blood: | n/a | n/a |
10 | HEY1 | chr2:231438502-231438678 | K562 | blood: | n/a | n/a |
11 | HEY1 | chr2:231438539-231438674 | HepG2 | liver: | n/a | n/a |
12 | IRF1 | chr2:231440416-231440701 | K562 | blood: | n/a | n/a |
13 | JUN | chr2:231440230-231440857 | K562 | blood: | n/a | chr2:231440575-231440584 |
14 | JUND | chr2:231440426-231440597 | HepG2 | liver: | n/a | chr2:231440575-231440584 chr2:231440574-231440585 |
15 | JUND | chr2:231440398-231440760 | K562 | blood: | n/a | chr2:231440575-231440584 chr2:231440574-231440585 |
16 | MAX | chr2:231440341-231440741 | K562 | blood: | n/a | chr2:231440531-231440542 chr2:231440531-231440542 chr2:231440532-231440541 chr2:231440531-231440542 |
17 | MAX | chr2:231440263-231440849 | HCT-116 | colon: | n/a | chr2:231440531-231440542 chr2:231440531-231440542 chr2:231440532-231440541 chr2:231440531-231440542 |
18 | MAX | chr2:231440403-231440668 | K562 | blood: | n/a | chr2:231440531-231440542 chr2:231440531-231440542 chr2:231440532-231440541 chr2:231440531-231440542 |
19 | MAX | chr2:231440365-231440689 | K562 | blood: | n/a | chr2:231440531-231440542 chr2:231440531-231440542 chr2:231440532-231440541 chr2:231440531-231440542 |
20 | MAX | chr2:231440402-231440678 | SK-N-SH | brain: | n/a | chr2:231440531-231440542 chr2:231440531-231440542 chr2:231440532-231440541 chr2:231440531-231440542 |
21 | MAX | chr2:231440356-231440747 | NB4 | blood: | n/a | chr2:231440531-231440542 chr2:231440531-231440542 chr2:231440532-231440541 chr2:231440531-231440542 |
22 | MAZ | chr2:231440495-231440619 | K562 | blood: | n/a | chr2:231440531-231440542 chr2:231440531-231440542 chr2:231440532-231440541 chr2:231440531-231440542 |
23 | MXI1 | chr2:231440446-231440657 | K562 | blood: | n/a | chr2:231440531-231440540 |
24 | MYC | chr2:231440391-231440718 | K562 | blood: | n/a | chr2:231440531-231440542 chr2:231440531-231440542 chr2:231440532-231440541 chr2:231440531-231440542 |
25 | MYC | chr2:231440358-231440711 | NB4 | blood: | n/a | chr2:231440531-231440542 chr2:231440531-231440542 chr2:231440532-231440541 chr2:231440531-231440542 |
26 | MYC | chr2:231440397-231440711 | K562 | blood: | n/a | chr2:231440531-231440542 chr2:231440531-231440542 chr2:231440532-231440541 chr2:231440531-231440542 |
27 | NR2F2 | chr2:231437657-231437971 | K562 | blood: | n/a | n/a |
28 | PAX5 | chr2:231438455-231438650 | GM12878 | blood: | n/a | n/a |
29 | POLR2A | chr2:231437967-231438307 | GM12878 | blood: | n/a | n/a |
30 | POLR2A | chr2:231438444-231438659 | GM12892 | blood: | n/a | n/a |
31 | POLR2A | chr2:231439727-231439861 | GM12878 | blood: | n/a | n/a |
32 | POLR2A | chr2:231440074-231440123 | GM12878 | blood: | n/a | n/a |
33 | POLR2A | chr2:231440041-231440065 | GM12878 | blood: | n/a | n/a |
34 | POLR2A | chr2:231438484-231438654 | GM12878 | blood: | n/a | n/a |
35 | POLR2A | chr2:231440319-231440664 | GM12878 | blood: | n/a | n/a |
36 | POLR2A | chr2:231438484-231438698 | A549 | lung: | n/a | n/a |
37 | POLR2A | chr2:231438459-231438638 | GM12891 | blood: | n/a | n/a |
38 | POLR2A | chr2:231437816-231438006 | GM12878 | blood: | n/a | n/a |
39 | POLR2A | chr2:231438416-231438636 | Hela-S3 | cervix: | n/a | n/a |
40 | POLR2A | chr2:231440500-231440556 | K562 | blood: | n/a | n/a |
41 | POLR2A | chr2:231438498-231438595 | A549 | lung: | n/a | n/a |
42 | POLR2A | chr2:231440245-231440445 | GM12878 | blood: | n/a | n/a |
43 | POLR2A | chr2:231438331-231438844 | GM12878 | blood: | n/a | n/a |
44 | POLR2A | chr2:231438352-231438672 | GM12878 | blood: | n/a | n/a |
45 | POLR2A | chr2:231437746-231437916 | GM12878 | blood: | n/a | n/a |
46 | POLR2A | chr2:231439986-231440180 | GM12878 | blood: | n/a | n/a |
47 | POLR2A | chr2:231438454-231438631 | Hela-S3 | cervix: | n/a | n/a |
48 | POLR2A | chr2:231440506-231440530 | GM12878 | blood: | n/a | n/a |
49 | POLR2A | chr2:231438345-231438860 | GM12892 | blood: | n/a | n/a |
50 | RCOR1 | chr2:231440507-231440526 | K562 | blood: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SP110-1 | chr2:231440637-231440741 | ENSG00000235419.1 |
2 | lnc-SP110-1 | chr2:231440637-231440741 | ENSG00000235419.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
TPM3P8 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145921249 | chr2:231437940-231437941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556790930 | chr2:231437951-231437952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568578912 | chr2:231438000-231438001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185052682 | chr2:231438001-231438002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553495154 | chr2:231438058-231438059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373526988 | chr2:231438062-231438063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571796577 | chr2:231438094-231438095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs55795378 | chr2:231438097-231438098 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs557332420 | chr2:231438126-231438127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191084701 | chr2:231438180-231438181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs56007290 | chr2:231438198-231438199 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs531595903 | chr2:231438213-231438214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs62192833 | chr2:231438225-231438226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561999519 | chr2:231438260-231438261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138964938 | chr2:231438275-231438276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs17276229 | chr2:231438296-231438297 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs181736871 | chr2:231438297-231438298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185895517 | chr2:231438337-231438338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs17276271 | chr2:231438347-231438348 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs570881727 | chr2:231438350-231438351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370122501 | chr2:231438372-231438373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550232971 | chr2:231438380-231438381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568718416 | chr2:231438387-231438388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs62192834 | chr2:231438388-231438389 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs191688458 | chr2:231438399-231438400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs62192835 | chr2:231438421-231438422 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs183081611 | chr2:231438466-231438467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557404490 | chr2:231438494-231438495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73104812 | chr2:231438502-231438503 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs555961811 | chr2:231438506-231438507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569714639 | chr2:231438519-231438520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543390370 | chr2:231438530-231438531 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs543909245 | chr2:231438545-231438546 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs112324089 | chr2:231438559-231438560 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs573876757 | chr2:231438566-231438567 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs541280178 | chr2:231438569-231438570 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs559596571 | chr2:231438591-231438592 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs17276306 | chr2:231438600-231438601 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs149552366 | chr2:231438606-231438607 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs564580719 | chr2:231438624-231438625 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs112672516 | chr2:231438625-231438626 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs550148360 | chr2:231438648-231438649 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs559485948 | chr2:231438649-231438650 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs62192836 | chr2:231438650-231438651 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs140076330 | chr2:231438672-231438673 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs73104822 | chr2:231438673-231438674 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs188364013 | chr2:231438731-231438732 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs539623652 | chr2:231438745-231438746 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs551096514 | chr2:231438767-231438768 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs68007066 | chr2:231438781-231438782 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 22429812 | CNVD |
Bladder cancer | 21909424 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Mental retardation | 20152051 | CNVD |
Cancer | 21183584 | CNVD |
Albright''s disease | 22277900 | CNVD |
Brachydactyly-Mental Retardation Syndrome | 22470819 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Autism | 18414403 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:231436600-231440000 | Weak transcription | Primary T cells from cord blood | blood |
2 | chr2:231439400-231440800 | ZNF genes & repeats | GM12878-XiMat | blood |
3 | chr2:231439800-231440200 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
4 | chr2:231439800-231440600 | Enhancers | Placenta | Placenta |
5 | chr2:231439800-231440800 | Enhancers | Fetal Thymus | thymus |
6 | chr2:231439800-231443800 | Enhancers | Primary T cells fromperipheralblood | blood |
7 | chr2:231440000-231440200 | Flanking Active TSS | Primary T cells from cord blood | blood |
8 | chr2:231440000-231440600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr2:231440000-231440800 | Enhancers | K562 | blood |
10 | chr2:231440000-231441000 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
11 | chr2:231440000-231441000 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
12 | chr2:231440000-231442200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
13 | chr2:231440000-231442600 | Weak transcription | Primary B cells from peripheral blood | blood |
14 | chr2:231440200-231440400 | Enhancers | Primary T cells from cord blood | blood |
15 | chr2:231440200-231440400 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
16 | chr2:231440200-231440800 | Flanking Active TSS | Primary T killer naive cells fromperipheralblood | blood |
17 | chr2:231440200-231443400 | Enhancers | Primary T helper cells fromperipheralblood | blood |
18 | chr2:231440400-231440600 | Flanking Active TSS | Primary T cells from cord blood | blood |
19 | chr2:231440400-231440800 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
20 | chr2:231440400-231440800 | Flanking Active TSS | Primary T killer memory cells from peripheral blood | blood |
21 | chr2:231440400-231440800 | Active TSS | A549 | lung |
22 | chr2:231440400-231441200 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
23 | chr2:231440600-231443400 | Enhancers | Primary T cells from cord blood | blood |